National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; WHO) treatment recommendations, ...
19 hours ago
1
13
A new research paper was published in Oncotarget entitled, "Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface."
Apr 16, 2024
0
0
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients ...
Feb 16, 2024
0
65
In the late nineteenth century, physicians started treating human disease with blood serum extracted from immunized horses. But those extracts—which contained antibodies that target disease agents—often produced disastrous ...
Jan 25, 2024
0
26
Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. But new research from the University of Georgia suggests that patients and caregivers may not experience ...
Jan 23, 2024
0
11
Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people. The ...
Jan 17, 2024
0
68
Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study led by Dana-Farber Cancer Institute scientists shows. Based on ...
Jan 5, 2024
0
125
The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies.
Jan 5, 2024
0
51
Sepideh Dolatshahi, an assistant professor of biomedical engineering at the University of Virginia, is spearheading an exploration of systems immunology in its crucial development phase—during pregnancy.
Dec 16, 2023
7
42
